Congenital adrenal hyperplasia: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Blanked the page)
Line 1: Line 1:
__NOTOC__
{{SI}}
{{CMG}}; {{AE}} {{CZ}}; {{Ammu}}


{{SK}} CAH; Adrenogenital syndrome
==Overview==
Congenital adrenal hyperplasia is a group of [[autosome|autosomal]] [[recessive]] [[disease]]s that result from multiple [[genetic]] mutations. The genes encode a number of enzymes that mediate the adrenal glands [[steroidogenesis]] pathway. As a result, mutations in such genes will result in various enzyme deficiencies that lead to a disequilibrium of the biochemical reactions mediating the production of cortisol, aldesterone, and androgens.<ref name="Warrell2005">{{cite book|author=David A. Warrell|title=Oxford textbook of medicine: Sections 18-33|url=https://books.google.com/books?id=hL1NKQJlY1IC&pg=PA261|accessdate=14 June 2010|year=2005|publisher=Oxford University Press|isbn=978-0-19-856978-7|pages=261–}}</ref> The outcome of congenital adrenal hyperplasia is either an excessive or deficient production of the aforementioned hormones, which alters the development of both [[primary sex characteristic|primary]] and [[secondary sex characteristic]]s among affected patients.<ref name="MilunskyMilunsky2010">{{cite book|author1=Aubrey Milunsky|author2=Jeff Milunsky|title=Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment|url=https://books.google.com/books?id=oKCmA4dOYtMC&pg=PA600|accessdate=14 June 2010|date=29 January 2010|publisher=John Wiley and Sons|isbn=978-1-4051-9087-9|pages=600–}}</ref> Congenital adrenal hyperplasia may be classified according to
biochemical enzyme deficiency into commonly five subtypes: [[lipoid congenital adrenal hyperplasia]], [[congenital adrenal hyperplasia due to 21-hydroxylase deficiency]], [[congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency]], [[congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency]], and [[congenital adrenal hyperplasia due to 11β-hydroxylase deficiency]].
===Congenital Adrenal Hyperplasia===
* The figure below illustrates the biochemical reactions of the adrenal glands [[steroidogenesis]] pathway:
<br>
[[Image:DHEA1_svg.png|thumb|center|800px|Production of DHEA from Cholesterol. ([[Cortisol]] is a [[glucocorticoid]].)]]
==Historical Perspective==
==Classification==
* Congenital adrenal hyperplasia may be classified according to biochemical enzyme deficiency into commonly the following types:
<br>
{{Familytree/start}}
{{Familytree|boxstyle=background: #E0FFFF;| | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | | |A01=<div style="width: 20em; padding:0.5em;">'''Congenital Adrenal Hyperplasia'''</div>}}
{{Familytree|boxstyle=background: #E0FFFF;| | | | |,|-|-|-|-|v|-|-|-|-|+|-|-|-|-|v|-|-|-|-|.| | | | | | | | | | | | | |}}
{{Familytree|boxstyle=background: #E0FFFF;| | | | B01 | | | B02 | | | B03 | | | B04 | | | B05 | | | | | | | | | | | |B01= <div style="width: 15em; padding:0.5em;">[[Lipoid congenital adrenal hyperplasia]]</div>|B02= <div style="width: 15em; padding:0.5em;">[[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency]]</div>|B03=  <div style="width: 15em; padding:0.5em;"> [[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency]]</div>|B04= <div style="width: 15em; padding:0.5em;"> [[Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency]] </div>|B05= <div style="width: 15em; padding:0.5em;"> [[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency]] </div>}}
{{Familytree/end}}
<br>
===Biochemistry===
* The table below lists the specific biochemical abnormalities present among the different types of congenital adrenal hyperplasia:
<br>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
|valign=top|
|+
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Common Medical Term'''
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''OMIM Number'''
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Enzyme'''
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Gene location'''
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Substrates'''
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Products'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
''' [[Congenital adrenal hyperplasia due to 21-hydroxylase deficiency|21-hydroxylase CAH]]'''
| style="padding: 5px 5px; background: #F5F5F5;"|
:{{OMIM|201910}}
| style="padding: 5px 5px; background: #F5F5F5;"|
:P450c21
| style="padding: 5px 5px; background: #F5F5F5;"|
:6p21.3
| style="padding: 5px 5px; background: #F5F5F5;"|
:17OH-progesterone→ <br/>[[Progesterone]] 
| style="padding: 5px 5px; background: #F5F5F5;"|
:11-deoxycortisol→<br/>[[11-deoxycorticosterone|DOC]]
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
''' [[Lipoid congenital adrenal hyperplasia|lipoid CAH]]<br/>(20,22-desmolase)'''
| style="padding: 5px 5px; background: #F5F5F5;"|
:{{OMIM|201710}}
| style="padding: 5px 5px; background: #F5F5F5;"|
:StAR<br/>P450scc
| style="padding: 5px 5px; background: #F5F5F5;"|
:8p11.2<br/>15q23-q24
| style="padding: 5px 5px; background: #F5F5F5;"|
:Transport of [[cholesterol]]→<br/>[[cholesterol]]
| style="padding: 5px 5px; background: #F5F5F5;"|
:Into mitochondria→<br/>[[Pregnenolone]]
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
'''  [[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency|17α-hydroxylase CAH]]'''
| style="padding: 5px 5px; background: #F5F5F5;"|
:{{OMIM|202110}}
| style="padding: 5px 5px; background: #F5F5F5;"|
:P450c17
| style="padding: 5px 5px; background: #F5F5F5;"|
:10q24.3
| style="padding: 5px 5px; background: #F5F5F5;"|
:[[pregnenolone]]→<br/>[[progesterone]]→<br/>17OH-pregnenolone→
| style="padding: 5px 5px; background: #F5F5F5;"|
:17OH-pregnenolone<br/>17OH-progesterone<br/>[[DHEA]]
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
'''[[Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency|3β-HSD CAH]]'''
| style="padding: 5px 5px; background: #F5F5F5;"|
:{{OMIM|201810}}
| style="padding: 5px 5px; background: #F5F5F5;"|
:3βHSD II
| style="padding: 5px 5px; background: #F5F5F5;"|
:1p13
| style="padding: 5px 5px; background: #F5F5F5;"|
:[[Pregnenolone]]→<br/>17OH-pregnenolone→<br/>[[DHEA]]→
| style="padding: 5px 5px; background: #F5F5F5;"|
:[[Progesterone]]<br/>17OH-progesterone<br/>[[androstenedione]]
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
'''[[Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency|11β-hydroxylase CAH]]'''
| style="padding: 5px 5px; background: #F5F5F5;"|
:{{OMIM|202010}}
| style="padding: 5px 5px; background: #F5F5F5;"|
:P450c11β
| style="padding: 5px 5px; background: #F5F5F5;"|
:8q21-22
| style="padding: 5px 5px; background: #F5F5F5;"|
:11-deoxycortisol→<br/>DOC→
| style="padding: 5px 5px; background: #F5F5F5;"|
:[[Cortisol]]<br/>[[Corticosterone]]
|}
==Pathophysiology==
==Causes==
==Differentiating {{PAGENAME}} from Other Diseases==
==Epidemiology and Demographics==
==Risk Factors==
==Screening==
==Natural History, Complications, and Prognosis==
==Diagnosis==
===Diagnostic Criteria===
===History and Symptoms===
===Physical Examination===
===Laboratory Findings===
===Imaging Findings===
===Other Diagnostic Studies===
==Treatment==
===Medical Therapy===
===Surgery===
===Prevention===
==Reference==
{{Reflist|2}}
[[Category:Endocrinology]]
{{WS}}
{{WH}}

Revision as of 17:58, 3 July 2017